Tamara S. Hannon, MD, MS

Tamara S. Hannon, MD, MS

Associate Professor of Pediatrics

Phone: (317) 944-3889
Fax: (317) 944-3882
Email: tshannon@iu.edu
705 Riley Hospital Drive, Room 5960  
Indianapolis, IN  46202



Pediatric Endocrinology and Diabetology

Areas of Interest

Type 1 diabetes; type 2 diabetes;  prediabetes; diabetes prevention; diabetes and obesity research.

Dr. Hannon is a board certified pediatric endocrinologist with specific training and expertise in patient-oriented clinical research in youth with obesity, conditions of insulin resistance, and diabetes.  She also serves as Director of the Pediatric Diabetes Program at Riley Hospital for Children, a program serving more than 1800 pediatric diabetes patients across the state of Indiana and surrounding states.  She is currently an investigator on multiple projects to prevent diabetes or restore insulin secretion in individuals with diabetes.  Her undergraduate degree is in Nutrition Science, from Purdue University.  She received her medical degree from Indiana University and did her pediatric residency and pediatric endocrinology fellowship at Riley Hospital for Children in Indianapolis, IN.


1992 Nutrition Science B.S., Purdue University
1996 MD, Indiana University
2005 MS Clinical Research, Indiana University

Honors & Awards

Society for Pediatric Research, Elected Member
President, Community Leadership Board, American Diabetes Association


Riley Children's Specialty Clinic
11590 North Meridian Street
Suite 300
Carmel, IN 46032

Deaconess Riley Children's Specialty Center
4133 Gateway Boulevard
Suite 220
Newburgh, IN 47630 

Research & Grants

I am currently co-investigator on multiple projects to prevent diabetes or restore insulin secretion in individuals with diabetes.  I am also interested in the identification and communication of risk factors for the development of diabetes, prevention strategies, and efforts to translate efficacious therapies into the community.

Current Grants

Computer Automation for Diagnosis & Management of Childhood Type 2 Diabetes, R01 DK092717, National Institutes of Health; National Institutes of Diabetes and Digestive and Kidney Diseases,  Co-Principal Investigator

Preservation of Beta Cell Function in Prediabetes/Early Type 2 Diabetes “Restoring Insulin Secretion (RISE),” U01 DK094438, National Institutes of Health; National Institutes of Diabetes and Digestive and Kidney Diseases, Co-Investigator

Primary Prevention of Diabetes in Children and Mothers at Increased Risk “Encourage Healthy Families,”  JBP Foundation; Investigator-Initiated Grant, Co-Investigator

Center for Pediatric Obesity and Diabetes Prevention Research, IUPUI Signature Centers of Excellence, IUPUI, Co-Investigator

Advancing Diabetes Management in Adolescents Using Health Information Technology, R24, National Institutes of Health, Co-Investigator

Representative PublicationsView All Publications

1. Childhood obesity and type 2 diabetes mellitus. Hannon TS, Rao G, Arslanian SA. Pediatrics. 2005 Aug;116(2):473-80. Review. PMID:16061606

2. Type 2 diabetes in children and adolescents: a review for the primary care provider. Hannon TS, Gungor N, Arslanian SA. Pediatr Ann. 2006 Dec;35(12):880-7. Review. No abstract available. PMID:17236435

3. Type 2 diabetes mellitus in youth: the complete picture to date. Gungor N, Hannon T, Libman I, Bacha F, Arslanian S. Pediatr Clin North Am. 2005 Dec;52(6):1579-609. PMID:16301084

4. Growth hormone treatment in adolescent males with idiopathic short stature: changes in body composition, protein, fat, and glucose metabolism.Hannon TS, Danadian K, Suprasongsin C, Arslanian SA.J Clin Endocrinol Metab. 2007 Aug;92(8):3033-9. Epub 2007 May 22. PMID:17519313

5. Sleep-disordered breathing in obese adolescents is associated with visceral adiposity and markers of insulin resistance.Hannon TS, Lee S, Chakravorty S, Lin Y, Arslanian SA. Int J Pediatr Obes. 2011 Apr;6(2):157-60. doi: 10.3109/17477166.2010.482156. Epub 2010 Jun 14. PMID:20545482

6. Longitudinal study of physiologic insulin resistance and metabolic changes of puberty.Hannon TS, Janosky J, Arslanian SA.Pediatr Res. 2006 Dec;60(6):759-63. Epub 2006 Oct 25. PMID:17065576

7. Effects of aerobic versus resistance exercise without caloric restriction on abdominal fat, intrahepatic lipid, and insulin sensitivity in obese adolescent boys: a randomized, controlled trial.Lee S, Bacha F, Hannon T, Kuk JL, Boesch C, Arslanian S.Diabetes. 2012 Nov;61(11):2787-95. doi: 10.2337/db12-0214. Epub 2012 Jun 29. PMID:22751691

8. Relationships among obstructive sleep apnea, anthropometric measures, and neurocognitive functioning in adolescents with severe obesity.Hannon TS, Rofey DL, Ryan CM, Clapper DA, Chakravorty S, Arslanian SA.J Pediatr. 2012 May;160(5):732-5. doi: 10.1016/j.jpeds.2011.10.029. Epub 2011 Dec 3. PMID:22137667

9. B-cell autoimmunity in overweight non-diabetic youth: any implications?Libman IM, Barinas-Mitchell E, Marcovina S, Bacha F, Hannon T, Tfayli H, Lee SJ, Bansal S, Robertson R, Arslanian S.Pediatr Diabetes. 2011 May;12(3 Pt 2):207-11. doi: 10.1111/j.1399-5448.2010.00697.x. Epub 2010 Sep 7. PMID:21518410

10. Use of markers of dyslipidemia to identify overweight youth with insulin resistance.Hannon TS, Bacha F, Lee SJ, Janosky J, Arslanian SA.Pediatr Diabetes. 2006 Oct;7(5):260-6. PMID:17054447

11. Hyperinsulinemia in African-American adolescents compared with their American white peers despite similar insulin sensitivity: a reflection of upregulated beta-cell function?Hannon TS, Bacha F, Lin Y, Arslanian SA.Diabetes Care. 2008 Jul;31(7):1445-7. doi: 10.2337/dc08-0116. Epub 2008 Apr 16. PMID:18417751

12. Differences in stimulated androgen levels in black and white obese adolescent females.Hannon TS, Arslanian SA.J Pediatr Adolesc Gynecol. 2012 Feb;25(1):82-5. doi: 10.1016/j.jpag.2011.09.007. Epub 2011 Nov 16. PMID:22088317

13. Race and gender differences in the relationships between anthropometrics and abdominal fat in youth.Lee S, Kuk JL, Hannon TS, Arslanian SA.Obesity (Silver Spring). 2008 May;16(5):1066-71. doi: 10.1038/oby.2008.13. Epub 2008 Mar 6. PMID:18356853

14. Parents' Readiness to Change Affects BMI Reduction Outcomes in Adolescents with Polycystic Ovary Syndrome.Jakubowski KP, Black JJ, El Nokali NE, Belendiuk KA, Hannon TS, Arslanian SA, Rofey DL.J Obes. 2012;2012:298067. doi: 10.1155/2012/298067. Epub 2012 Aug 26. PMID:22970350

15. Depressive symptoms and metabolic markers of risk for type 2 diabetes in obese adolescents.Hannon TS, Rofey DL, Lee S, Arslanian SA.Pediatr Diabetes. 2013 Nov;14(7):497-503. doi: 10.1111/pedi.12035. Epub 2013 Mar 31. PMID:23551914

16. Diabetes mellitus and growth in children and adolescents.Hannon TS, Rogol AD.J Pediatr. 2012 Jun;160(6):893-4. doi: 10.1016/j.jpeds.2012.01.037. Epub 2012 Feb 22. No abstract available. PMID:22361220

17. Obstructive sleep apnoea in obese adolescents and cardiometabolic risk markers.Watson SE, Li Z, Tu W, Jalou H, Brubaker JL, Gupta S, Huber JN, Carroll A, Hannon TS.Pediatr Obes. 2013 Sep 17. doi: 10.1111/j.2047-6310.2013.00198.x. [Epub ahead of print] PMID:24106092

18. Effects of recombinant human growth hormone on protein turnover in the fasting and fed state in adolescents with Crohn disease.Hannon TS, DiMeglio LA, Pfefferkorn MD, Carroll AE, Denne SC.J Pediatr Endocrinol Metab. 2011;24(9-10):633-40. PMID:22145448

19. Childhood obesity: a simple equation with complex variables.Strock GA, Cottrell ER, Abang AE, Buschbacher RM, Hannon TS.J Long Term Eff Med Implants. 2005;15(1):15-32. Review. PMID:15715513

20. Is McCune-Albright syndrome overlooked in subjects with fibrous dysplasia of bone?Hannon TS, Noonan K, Steinmetz R, Eugster EA, Levine MA, Pescovitz OH.J Pediatr. 2003 May;142(5):532-8. PMID:12756386